Proton therapy CBCT imaging solution across Proteus Portfolio providing clarity and confidence in IGPT Louvain-la-Neuve, Belgium, May 13, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of proton therapy solutions for the treatment of cancer, today announces the introduction of AdaPTinsight XR, the next generation of its Cone Beam Computed Tomography (CBCT) imaging capabilities, designed to enhance visualization and support conf ...